Softwr

Research · head to head

LabVantage vs OpenEye, Cadence Molecular Sciences

LabVantage logo

LabVantage

Research

Enterprise LIMS with integrated ELN and biobanking capability

From
On request
Rated
-
Full reviewWebsite
OpenEye, Cadence Molecular Sciences logo

OpenEye, Cadence Molecular Sciences

Research

Computational chemistry toolkits and the Orion cloud platform, now inside Cadence

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: LabVantage enterprise implementation weight, with configuration and validation measured in many months; OpenEye, Cadence Molecular Sciences the free Public Domain Research Licence requires surrendering intellectual property rights and publishing results into the public domain, which rules it out for any academic group with a technology transfer office or patent ambitions.
  • They diverge on capability: LabVantage covers Unified platform, OpenEye, Cadence Molecular Sciences covers OMEGA.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LabVantage and OpenEye, Cadence Molecular Sciences actually diverge.

Attributes where LabVantage and OpenEye, Cadence Molecular Sciences differ
AttributeLabVantageOpenEye, Cadence Molecular Sciences
PlatformsWeb, Cloud, On-premiseLinux, Windows, macOS, Web, API

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LabVantage

  • Unified platform
  • Biobanking
  • Instrument integration
  • Industry accelerators
  • Regulatory compliance
  • Web architecture

Only in OpenEye, Cadence Molecular Sciences

  • OMEGA
  • ROCS
  • ROCS X
  • Orion platform
  • Programmatic toolkits
  • Academic routes
  • Structure preparation
  • Docking and scoring

What people use each for

The jobs each tool is most often brought in to do.

LabVantage

  • Laboratories wanting LIMS and ELN from one vendor rather than integrating twonot OpenEye, Cadence Molecular Sciences
  • Biobanks managing specimen provenance, consent and long-term storagenot OpenEye, Cadence Molecular Sciences
  • Pharmaceutical research organisations spanning discovery through QCnot OpenEye, Cadence Molecular Sciences
  • Multi-site laboratory networks standardising on a single platformnot OpenEye, Cadence Molecular Sciences

OpenEye, Cadence Molecular Sciences

  • A pharmaceutical discovery team screening a multi-billion compound library by three-dimensional shape rather than by two-dimensional similaritynot LabVantage
  • A computational chemist embedding conformer generation into an internal pipeline through the Python toolkitsnot LabVantage
  • A university group publishing openly that can accept the public domain licence terms in exchange for zero costnot LabVantage
  • A biotech scaling virtual screening on cloud compute without building its own clusternot LabVantage

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LabVantage

  • Enterprise implementation weight, with configuration and validation measured in many months
  • Pricing is quote-based with no public entry point
  • The unified platform argument only pays off for laboratories that genuinely need all four capabilities; those needing only LIMS may find focused competitors better
  • Smaller installed base than LabWare, which matters in conservative laboratory procurement
  • Industry accelerators shorten implementation but do not remove the need for laboratory-specific configuration

OpenEye, Cadence Molecular Sciences

  • The free Public Domain Research Licence requires surrendering intellectual property rights and publishing results into the public domain, which rules it out for any academic group with a technology transfer office or patent ambitions.
  • Free academic licences are renewable but re-evaluated annually with no guarantee of continuation, so a multi-year research programme has no assured software entitlement beyond the current year.
  • OpenEye now sits inside Cadence Design Systems, whose core business is chip design, so the roadmap and licensing culture are set by a company for which molecular sciences is one growth line among several.
  • Commercial pricing is entirely unpublished and structured as annual subscriptions with separate Orion compute, making total cost of a screening programme hard to forecast before contracting.
  • The toolkits assume real computational chemistry expertise; they are libraries and applications for specialists, not an interface a medicinal chemist can drive without training.

Pricing, plan by plan

LabVantage

On request
  • LabVantage$undefined/year
    • LIMS
    • ELN
    • LES

OpenEye, Cadence Molecular Sciences

On request
  • Commercial licence$undefined/year
    • Annual subscription priced through Cadence sales
    • Toolkits and applications licensed separately from the Orion platform
    • Orion compute billed on top of software entitlements
  • Academic Package$undefined/year
    • Paid annual subscription for university groups under ten members
    • Includes support
    • Researchers retain intellectual property rights
  • Public Domain Research LicenceFree
    • No cost
    • No support of any kind
    • No intellectual property rights retained

Which should you pick?

Choose LabVantage if

  • You need unified platform.
  • You work on Web, Cloud, On-premise.
  • You also want biobanking.
LabVantage review

Choose OpenEye, Cadence Molecular Sciences if

  • You need omega.
  • You work on Linux, Windows, macOS, Web, API.
  • You also want rocs.
OpenEye, Cadence Molecular Sciences review

Questions people ask

Is LabVantage or OpenEye, Cadence Molecular Sciences better?
Neither clearly leads. LabVantage starts at On request and OpenEye, Cadence Molecular Sciences at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LabVantage or OpenEye, Cadence Molecular Sciences?
LabVantage starts at On request and OpenEye, Cadence Molecular Sciences at On request.
Does LabVantage or OpenEye, Cadence Molecular Sciences run on more platforms?
LabVantage runs on Web, Cloud, On-premise. OpenEye, Cadence Molecular Sciences runs on Linux, Windows, macOS, Web, API.
What is LabVantage best used for?
LabVantage is most often used for laboratories wanting lims and eln from one vendor rather than integrating two, biobanks managing specimen provenance, consent and long-term storage, pharmaceutical research organisations spanning discovery through qc, multi-site laboratory networks standardising on a single platform. Of those, laboratories wanting lims and eln from one vendor rather than integrating two and biobanks managing specimen provenance, consent and long-term storage are not what OpenEye, Cadence Molecular Sciences is typically brought in for.
What can LabVantage do that OpenEye, Cadence Molecular Sciences cannot?
LabVantage covers Unified platform, Biobanking, Instrument integration, Industry accelerators. OpenEye, Cadence Molecular Sciences covers OMEGA, ROCS, ROCS X, Orion platform.

Answered from the vendors’ own pages

LabVantage: What does the unified platform actually mean?

LIMS, electronic laboratory notebook, laboratory execution and scientific data management as one product. Laboratories that would otherwise integrate and validate four vendors avoid that work.

OpenEye, Cadence Molecular Sciences: Is OpenEye still OpenEye?

It trades as OpenEye, Cadence Molecular Sciences, and is part of Cadence Design Systems following acquisition. The product names OMEGA, ROCS and Orion continue.

LabVantage: Is biobanking really different?

Yes. Specimen provenance, consent tracking and decades-long storage are distinct from test result management, and the number of platforms handling them properly is small.

OpenEye, Cadence Molecular Sciences: Can academics use it for free?

Yes, through the Public Domain Research Licence or a Teaching Licence, but both come with no support and no intellectual property rights. Keeping IP rights and support requires the paid Academic Package.

LabVantage: What does it cost?

Not published. Enterprise annual licensing plus implementation, quoted on scope.

OpenEye, Cadence Molecular Sciences: What is ROCS X?

A machine learning enabled extension of ROCS shape search, built on the Orion platform, aimed at screening chemical spaces in the trillions of molecules.

LabVantage: Do the industry accelerators shorten implementation?

They help by supplying pre-configured workflows for a vertical. They do not remove laboratory-specific configuration or, in regulated settings, validation.

OpenEye, Cadence Molecular Sciences: Is commercial pricing published?

No. Commercial licences are annual subscriptions quoted through Cadence sales, with Orion compute charged separately.

LabVantage: How does it compare to LabWare?

LabWare has the larger installed base and deeper pharmaceutical QC dominance. LabVantage argues on the unified LIMS and ELN platform and on biobanking. Both are enterprise projects.

Share

Related pages

More on LabVantage

More on OpenEye, Cadence Molecular Sciences

Keep looking

Other head to heads